Adherence in 2025: How Close Are We to Finally Solving the Retinal Treatment Burden?
“Every time I miss a shot, I see less. But I also might lose my job if I go. What…
GLP-1 Agonists Associated with Doubled Risk of Neovascular AMD, Study Finds
Blockbuster meds, blockbuster risks? Trending GLP-1s (like Ozempic) are now raising red flags for nAMD. A new population-based cohort study…
popular posts
latest posts